D. C. Rees Et Al. , "A randomized, placebo-controlled, double-blind trial of canakinumab in children and young adults with sickle cell anemia," BLOOD , vol.139, no.17, pp.2642-2652, 2022
Rees, D. C. Et Al. 2022. A randomized, placebo-controlled, double-blind trial of canakinumab in children and young adults with sickle cell anemia. BLOOD , vol.139, no.17 , 2642-2652.
Rees, D. C., KILINÇ, Y., ÜNAL, S., Dampier, C., Pace, B. S., Kaya, B., ... Trompeter, S.(2022). A randomized, placebo-controlled, double-blind trial of canakinumab in children and young adults with sickle cell anemia. BLOOD , vol.139, no.17, 2642-2652.
Rees, David Et Al. "A randomized, placebo-controlled, double-blind trial of canakinumab in children and young adults with sickle cell anemia," BLOOD , vol.139, no.17, 2642-2652, 2022
Rees, David C. Et Al. "A randomized, placebo-controlled, double-blind trial of canakinumab in children and young adults with sickle cell anemia." BLOOD , vol.139, no.17, pp.2642-2652, 2022
Rees, D. C. Et Al. (2022) . "A randomized, placebo-controlled, double-blind trial of canakinumab in children and young adults with sickle cell anemia." BLOOD , vol.139, no.17, pp.2642-2652.
@article{article, author={David C. Rees Et Al. }, title={A randomized, placebo-controlled, double-blind trial of canakinumab in children and young adults with sickle cell anemia}, journal={BLOOD}, year=2022, pages={2642-2652} }